Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD

NACompletedINTERVENTIONAL
Enrollment

117

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Lisdexamfetamine

During the first 4 weeks of treatment, the dosage of Lisdexamfetamine will be adjusted based on the patient's response to the medication. The patient will then be maintained at the lowest effective dose for the remaining 8 weeks of treatment.

DRUG

Placebo

Placebo dosing will parallel that of Lisdexamfetamine.

Trial Locations (1)

10032

New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Shire

INDUSTRY

lead

New York State Psychiatric Institute

OTHER